Skip to main content

Table 4 Ability to perform activities of daily living, quality of life and level of physical activity of patients with Takayasu arteritis and the control group

From: Increased modifiable cardiovascular risk factors in patients with Takayasu arteritis: a multicenter cross-sectional study

  TAK (n=20) CTR (n=16) P value
HAQ (0.00–3.00) 0.56 (0.12–0.87) 0.00 (0.00–0.00) < 0.001
SF-36 (0–100)
 Functional Capacity 62.5 (46.2–88.7) 100.0 (95.0–100.0) < 0.001
 Physical function 50.0 (0.0–100.0) 100.0 (100.0–100.0) 0.008
 Pain 41.0 (34.2–63.5) 84.0 (69.2–100.0) < 0.001
 General health 61.0 (43.2–80.7) 92.0 (79.5–97.7) < 0.001
 Vitality 55.0 (35.0–72.5) 77.5 (55.0–85.0) 0.066
 Social aspects 88.0 (66.0–100.0) 100.0 (84.7–100.0) 0.194
 Emotional aspects 100.0 (33.0–100.0) 100.0 (67.0–100.0) 0.195
 Mental health 60.0 (53.0–84.0) 82.0 (75.0–97.0) 0.034
WIQ (0–100)
 Walking distance 68.0 (37.3–100.0) 100.0 (100.0–100.0) < 0.001
 Walking speed 64.1 (38.6–79.9) 100.0 (97.3–100.0) < 0.001
 Ability to climb stairs 58.3 (42.7–85.4) 100.0 (96.7–100.0) < 0.001
 Overall score 64.4 (42.4–86.9) 100.0 (88.9–100.0) < 0.001
IPAQ-SF (%)
 Low 14 (60.0) 3 (18.7) 0.013
 Moderate 6 (30.0) 9 (56.2) 0.080
 High 0 2 (12.5)
 METs per week 453.0 (240.0–751.7) 1693 (1089.0–2206.0) < 0.001
  1. Data are presented as median (25–75%) or percentage (%)
  2. CTR Control group, HAQ Health Assessment Questionnaire, IPAQ-SF International Physical Activity Questionnaire Short Version, METs Metabolic equivalent, SF-36 Short Form Health Survey, TAK Takayasu arteritis, WIQ Walking Impairment Questionnaire